Sandra Barbosa‐da‐Silva

ORCID: 0000-0003-3866-0912
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Diet, Metabolism, and Disease
  • Diet and metabolism studies
  • Liver Disease Diagnosis and Treatment
  • Adipose Tissue and Metabolism
  • Pancreatic function and diabetes
  • Birth, Development, and Health
  • Peroxisome Proliferator-Activated Receptors
  • Dietary Effects on Health
  • Adipokines, Inflammation, and Metabolic Diseases
  • Endoplasmic Reticulum Stress and Disease
  • Drug Transport and Resistance Mechanisms
  • Microbial Metabolites in Food Biotechnology
  • Regulation of Appetite and Obesity
  • Diabetes Treatment and Management
  • Pediatric Urology and Nephrology Studies
  • Business and Management Studies
  • Urban Development and Societal Issues
  • Urban and sociocultural dynamics
  • Gut microbiota and health
  • Cardiovascular Disease and Adiposity
  • Cardiovascular Function and Risk Factors
  • Cardiovascular Effects of Exercise
  • Media and Communication Studies
  • Pelvic floor disorders treatments
  • Cardiovascular and exercise physiology

Universidade do Estado do Rio de Janeiro
2014-2023

Morpho (United States)
2022

Humanitas University
2019

Creative Research Enterprises (United States)
2019

Escola da Cidade
2019

Max Planck Institute for Metabolism Research
2015

Guarulhos University
2013

Semaglutide (GLP-1 agonist) was approved for treating obesity. Although the effects on weight loss and metabolism are known, responses of adipocytes to semaglutide yet limited. C57BL/6 male mice (n = 20/group) were fed a control diet (C) or high-fat (HF) 16 weeks then separated into four groups 10/group) an additional weeks: C, C semaglutide, HF, HF semaglutide. Epididymal white adipose tissue (eWAT) subcutaneous (sWAT) fat pads studied with biochemistry, immunohistochemistry/fluorescence,...

10.1002/cbf.3751 article EN Cell Biochemistry and Function 2022-09-28

Background Obesity is associated with low-grade chronic inflammation attributed to dysregulated production, release of cytokines and adipokines glucose-insulin homeostasis dyslipidemia. Nutritional interventions such as dieting are often accompanied by repeated bouts weight loss regain, a phenomenon known cycling (WC). Methods In this work we studied the effects WC on feed efficiency, blood lipids, carbohydrate metabolism, adiposity inflammatory markers in C57BL/6 male mice that two or three...

10.1371/journal.pone.0039837 article EN cc-by PLoS ONE 2012-07-25

To evaluate the pleiotropic effects of empagliflozin in liver through lipogenesis, beta-oxidation, and endoplasmic reticulum stress pathways. Male C57Bl/6 mice, 3 months age, received a control diet (C, 10% lipids, n = 20) or high-fat (HF, 50% for 10 weeks, after that, groups were subdivided to receive empagliflozin, during 5 weeks at dose mg/kg/day added diets, totalizing four groups: C, C-EMPA, HF, HF-EMPA. We performed biochemical analyzes, oral glucose tolerance test, homeostasis model...

10.1016/j.mce.2019.110539 article EN publisher-specific-oa Molecular and Cellular Endocrinology 2019-08-13

Intermittent fasting (IF) is a nutritional intervention with significant metabolic effects on the liver that are not yet fully understood. The aim of this study was to investigate IF body mass, lipid profile, glucose metabolism, lipogenesis, β-oxidation, and inflammation.We used cellular molecular techniques 3-mo-old male C57 BL/6 mice were fed control (10% kcal fat), high-fat (HF; 50% or high-fructose (HFr; fructose) diets for 8 wk. Half animals submitted (1 d fed, 1 fast) an additional 4...

10.1016/j.nut.2019.02.020 article EN publisher-specific-oa Nutrition 2019-03-28

Changes in feeding habits are the primary environmental factors (though modifiable) commonly correlated with increase diseases such as obesity and associated comorbidities.

10.1039/c5fo00251f article EN Food & Function 2015-01-01

To assess the effects of peroxisome proliferator-activated receptor (PPAR) agonists on glucose tolerance and hepatic lipid metabolism in diet-induced obese mice. Male C57BL/6 mice received a standard chow diet (SC, 10% energy as lipids) or high-fat (HF, 50% for 10 weeks, after which treatment was initiated, forming groups: SC group, HF HF-BZ group (HF + bezafibrate, pan-PPAR agonist), HF-WY WY-14643, PPARalpha agonist) HF-GW GW1929, PPARgamma agonist). Treatments lasted four weeks. Insulin...

10.1016/j.lfs.2015.02.003 article EN publisher-specific-oa Life Sciences 2015-03-04

Studies show that the continuous consumption of fructose can lead to nonalcoholic fatty liver disease (NAFLD) and steatohepatitis. We aimed investigate role Metformin in an animal model injury caused by intake, focusing on molecular markers lipogenesis, beta-oxidation, antioxidant defenses. Male three months old C57BL/6 mice were divided into control group (C) (F, 47% fructose), maintained for ten weeks. After, groups received or vehicle a further eight weeks: (C), + (CM), (F), (FM)....

10.1016/j.biopen.2017.01.002 article EN cc-by-nc-nd Biochimie Open 2017-02-04

Intermittent fasting (IF) sets the preference for fats as fuel and is linked to beneficial metabolic outcomes; however, effects in renin-angiotensin system (RAS) heart remains be determined. We hypothesized that IF improves blood pressure lipid profiles due a less activated local RAS left ventricle of mice, irrespective dietary scheme. This study aimed evaluate intermittent on cardiovascular parameters (LV) mice fed either high-fat (HF) or high-fructose diet (HFru). Metabolic alterations...

10.1016/j.nutres.2018.12.005 article EN publisher-specific-oa Nutrition Research 2018-12-13

Type 2 diabetes mellitus (DM2) is the most common chronic metabolic disease, affecting approximately 6% of adult population in Western world.This condition a major cause cardiovascular blindness, renal failure, and amputations, with increasing prevalence worldwide.The influence obesity on type risk determined by degree body fat localization, insulin resistance (IR) being main link between these diseases.Experimental studies have shown that dietary factors, particularly lipids, are strongly...

10.4067/s0717-95022014000100046 article EN International Journal of Morphology 2014-03-01

Obesity has been associated with hepatic overexpression of the renin-angiotensin system (RAS).To evaluate action two angiotensin II (ANGII) receptor blockers (losartan or telmisartan) on modulation local RAS and resulting metabolic effects in a diet-induced obesity murine model.Twenty C57BL/6 mice were randomly divided into nutritional groups for 10 wk: control group (C, n = 5, 10% energy as fat) high-fat (HF, 15, 50% fat). After treatment started, HF was three groups: untreated (n 5),...

10.4254/wjh.v11.i4.359 article EN World Journal of Hepatology 2019-04-25

Weight cycling (WC) is frequent in obesity treatment. We evaluated the degree of regression liver damage WC.C57BL/6 male mice received standard chow (SC, 10% energy from lipids) or high-fat diet (HF, 60% for 6 months (SC6 HF6) a that alternated every 2 (SC2/HF2/SC2 HF2/SC2/HF2).The body mass gain followed HF intake and induced WC animals. The alanine aminotransferase, triglyceride cholesterol levels were higher groups receiving any period. plasma insulin glucose highest HF6 HF2/SC2/HF2...

10.1111/hepr.12138 article EN Hepatology Research 2013-04-18

Aim The aim of this study was to investigate the effects rosuvastatin in a model diet‐induced obesity and non‐alcoholic fatty liver disease, with attention activation hepatic stellate cells (HSCs). Method Male C57BL/6 mice received control diet (C; 10% energy as lipids) or high‐fat (HF; 50% for 12 weeks, followed by 7 weeks treatment. Group CR + rosuvastatin; group HFR rosuvastatin. Results HF showed higher insulin, total cholesterol, triacylglycerol, leptin levels than C group, all which...

10.1111/hepr.12821 article EN Hepatology Research 2016-09-21

El consumo de fructosa ha aumentado en los últimos 50 años por la incorporación a dieta jarabe maíz alto (JMAF), presente productos industrializados, como las bebidas azucaradas. Se puede asociar ingesta altas concentraciones con el aumento obesidad y trastornos metabólicos. La fructosa, un azúcar natural que se encuentra muchas frutas, consume cantidades significativas dietas occidentales. En iguales, es más dulce glucosa o sacarosa y, lo tanto, usa comúnmente edulcorante. Debido al...

10.4067/s0717-95022019000301058 article ES International Journal of Morphology 2019-07-18

Aims. The cardiobenefits of empagliflozin are multidimensional, and some mechanisms still unclear. aim the present study was to evaluate effect treatment with on biometric parameters gene expression in local cardiac RAS, oxidative stress, endoplasmic reticulum pathways a mouse model. Main Methods. Forty male C57BL/6 mice were fed control (C) or high-fat (HF) diets for 10 weeks. After that, groups redistributed according empagliflozin—CE HFE. administered via food 5 weeks (10 mg/kg/day). We...

10.1155/2022/8861911 article EN cc-by Journal of the Renin-Angiotensin-Aldosterone System 2022-01-01

Scope To analyze the effects of fexaramine (FEX), as an intestinal FXR agonist, on modulation microbiota and ileum mice fed a high‐fat (HF) diet. Methods results Three‐month‐old C57Bl/6 male are divided into two groups received control (C, 10% energy from lipids) or HF (50% diet for 12 weeks. They subdivided C, C + FEX, HF, FEX groups. is administered (FEX‐5 mg kg −1 ) via orogastric gavage three Body mass (BM), glucose metabolism, qPCR 16S rRNA gene expression, bile acids (BAs), tight...

10.1002/mnfr.202300148 article EN Molecular Nutrition & Food Research 2023-12-12

To investigate the effects of linagliptin treatment on hepatic energy metabolism and ER stress in high-fat-fed C57BL/6 mice.Forty male mice, three months age, received a control diet (C, 10% lipids as energy, n = 20) or high-fat (HF, 50% for 10 weeks. The groups were randomly subdivided into four to receive linagliptin, five weeks, at dose 30 mg/kg/day added diets: C, C-L, HF, HF-L groups.The HF group showed higher body mass, total cholesterol levels triacylglycerol than C group, all which...

10.1016/j.mce.2020.110804 article EN publisher-specific-oa Molecular and Cellular Endocrinology 2020-04-04

Both Hepatic Lipogenesis and Beta-Oxidation are Altered in Offspring of Mothers Fed a High-Fat Diet the First Two Generations (F1 F2) La Lipogénesis Hepática y la Beta-Oxidación están Alteradas en las Crías de Madres Alimentadas con una

10.4067/s0717-95022015000400052 article EN International Journal of Morphology 2015-12-01

RESUMEN Uno de los endulzantes más comúnmente utilizado es la fructosa.La fructosa directamente metabolizada en el hígado y se puede transformar glucosa, posteriormente almacenada como glicógeno constituyéndose una fuente energía para hepatocitos.Todo exceso convierte lípidos ejerciendo un efecto tóxico sobre hígado, similar al producido por alcohol, pudiendo provocar graso no alcohólico (NAFLD).El objetivo esta revisión reunir hallazgos recientes relación ingesta altas concentraciones su con NAFLD.

10.4067/s0717-95022017000200047 article ES International Journal of Morphology 2017-06-01
Coming Soon ...